CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer.

[1] CP-154,526 is under investigation for the potential treatment of alcoholism.

[2][3]

This article about an anxiolytic is a stub.

You can help Wikipedia by expanding it.